NASDAQ: KNSA - Kiniksa Pharmaceuticals, Ltd.

Yield per half year: -10.09%
Sector: Healthcare

Current price
19.25 $
Average price
3.13 $ -83.75%

Price based on EPS
2.61 $ -86.42%
Price according to DCF model (FCF)
6.72 $ -65.07%
0/10

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 2.61 $
Current price = 19.25 $ (difference = -86.42%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -0.6901 $
Current price = 19.25 $ (difference = -103.58%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 6.72 $
Current price = 19.25 $ (difference = -65.07%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription